應(yīng)用CRISPR-Cas9技術(shù)敲除ABCG2對(duì)結(jié)直腸癌細(xì)胞S1-M1-80的惡性生物學(xué)行為的研究
[Abstract]:Background: CRISPR (Clustered Regularly Interspersed Short Palindromic Repeats) is a regularly spaced cluster of short palindromic repeats, which can resist invading viruses and exogenous DNA, to induce Cas9 endonucleases to cleave its localized double-stranded DNA, through sg RNA to achieve knockout effect. Overexpression of ABCG2 gene is closely related to multidrug resistance in cancer cells. Overexpression of ABCG2 in cancer cells may lead to treatment failure. However, there are few reports about its relationship with other malignant biological behaviors in colorectal cancer besides multidrug resistance. In this study, we observed the effect of CRISPR-Cas9 knockout ABCG2 gene on multidrug resistance and other malignant biological behaviors of colorectal cancer. Methods: 1, construction of Lenti CRISPR v2 vector; 2, construction of ABCG2 knockout cell line; 3, detection of drug sensitivity of stable knock-out cell line; 4, drug accumulation test to evaluate the functional changes of the exocytosis of stable knock-out cell line; 5. MTT assay, flow cytometry, scratch test, Transwell invasion test and soft agarose clone formation test were used to detect the changes of cell biological behavior. Results: 1, Lenti CRISPR v2 vector was successfully constructed; 2, ABCG2 stable knock-out cell line was successfully constructed; 3, ABCG2 gene knockout cell line was more sensitive to drugs; (4) knockout ABCG2 increased intracellular drug accumulation in colorectal cancer cells; 5. Knockout of ABCG2 had little effect on the growth of colorectal cancer cells, and significantly weakened the cell cycle distribution, migration and invasive clone formation ability. Conclusion: CRISPR-Cas9 knockout of ABCG2 can inhibit the malignant biological behavior of colorectal cancer.
【學(xué)位授予單位】:暨南大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R735.34
【參考文獻(xiàn)】
相關(guān)期刊論文 前4條
1 胡均;李健;岳欣;王家倉(cāng);王俊鋒;柳建中;孔大陸;;Targeting BCRP/ABCG2 by RNA Interference Enhances the Chemotherapy Sensitivity of Human Colon Cancer Side Population Cells[J];Journal of Huazhong University of Science and Technology(Medical Sciences);2017年02期
2 武倩;邱敏;寧志豐;魏蕾;;沉默ABCG2對(duì)膀胱癌T24惡性生物學(xué)行為的影響[J];解剖學(xué)研究;2014年02期
3 張小彥;沈珊珊;鄒曉平;;ABCG2和NF-κB在結(jié)直腸癌的表達(dá)[J];江蘇醫(yī)藥;2013年23期
4 趙靜;張文;李文樺;張哲;朱丹;余綺荷;郭偉劍;李進(jìn);;MTHFR和ABCG2單核苷酸多態(tài)性對(duì)晚期結(jié)直腸癌一線化療療效的預(yù)測(cè)作用[J];腫瘤;2012年09期
相關(guān)碩士學(xué)位論文 前2條
1 劉輝;ABCG2表達(dá)變化對(duì)結(jié)直腸癌模型癌組織氧化應(yīng)激指標(biāo)及炎癥因子水平的影響[D];東南大學(xué);2016年
2 邵娜;結(jié)直腸癌中ABCG2與氧化應(yīng)激水平的相關(guān)性及其可能機(jī)制探討[D];南京大學(xué);2014年
,本文編號(hào):2447247
本文鏈接:http://sikaile.net/yixuelunwen/zlx/2447247.html